Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Neurodegeneration in a mouse model is abrogated by proteasome inhibitors that reverse impaired SNARE-complex assembly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The roles of intracellular protein-degradation pathways in neurodegeneration
Rubinsztein, D. C. (2006) · Nature · doi:10.1038/nature05291 · Cited by 1,625 · cited 1×
“brain cells try to cope with neurodegeneration (1, 21), we hypothesized that the increased proteasome activity in CSPa-deficient brains at a time of active neurodegeneration represents a reactive response to protect against the neurodegeneration observed in these mice.”
BackgroundFenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583 · cited 1×
“Injection solutions contained vehicle control (50% ethanol in H2O), lactacystin (Calbiochem; 100 mM) (which covalently modifies MB1 subunit of proteasome) (37), or epoxomicin (Calbiochem; 100 mM) [which modifies LMP7 (low–molecular mass protein 7), X, MECL1 (multicatalytic endopeptidase complex subunit 1), and Z catal…”
BackgroundEssential functions of synapsins I and II in synaptic vesicle regulation
Rosahl, T. W., Spillane, D., Missler, M., Herz, J., Selig, D. K., Wolff, J. R., Hammer, R. E., Malenka, R. C., & Südhof, T. C. (1995) · Nature · doi:10.1038/375488a0 · Cited by 719 · cited 1×
“Protein quantitation All quantitative immunoblotting experiments were performed with iodinated secondary antibodies as described (44).”
MethodSelf-citationA molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides
Gallardo, G., Schlüter, O. M., & Südhof, T. C. (2008) · Nature Neuroscience · doi:10.1038/nn2058 · Cited by 145
Self-citation
Cited by
The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
Lackie, R. E., Maciejewski, A., Ostapchenko, V. G., Marques-Lopes, J., Choy, W.-Y., Duennwald, M. L., Prado, V. F., & Prado, M. A. M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00254 · Cited by 374
Synaptic vesicle recycling: steps and principles
Rizzoli, S. O. (2014) · The EMBO Journal · doi:10.1002/embj.201386357 · Cited by 317
“More discoveries are to be expected since synaptic proteasome research has been gaining momentum during the last few years, especially due to potential links to neurodegeneration (for example, Sharma et al , 2011, 2011, 2012).”
Amyloid-β Oligomers May Impair SNARE-Mediated Exocytosis by Direct Binding to Syntaxin 1a
Yang, Y., Kim, J., Kim, H. Y., Ryoo, N., Lee, S., Kim, Y., Rhim, H., & Shin, Y.-K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.044 · Cited by 88
“APP/PS1 TG mice displayed a significant decrease in SNARE complex formation when compared with that of wild-type mice, which is in agreement with the results from the brains of AD patients (Sharma et al., 2012).”
BackgroundResultInfluentialCai, W., Li, L., Sang, S., Pan, X., & Zhong, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-022-00985-9 · Cited by 83
“First, Aβ perturbs the formation of fusion complexes, as reported in postmortem AD brains, where the SNARE complex, which is essential in driving synaptic vesicle fusion in the presynaptic active zone, is significantly reduced [217].”
BackgroundDeng, J., Koutras, C., Donnelier, J., Alshehri, M., Fotouhi, M., Girard, M., Casha, S., McPherson, P. S., Robbins, S. M., & Braun, J. E. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-01115-6 · Cited by 70
Metadata
- Authors
- Sharma, M., Burré, J., & Südhof, T. C.
- Venue
- Science Translational Medicine
- Published
- 2012-08-15
- Volume
- 4
- Issue
- 147
- Pages
- 147ra113-147ra113
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2153078270
- Cited by
- 73
- References
- 4
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.